The group of Araria-Goumidi [43] explored the influence of G-800A, C-509T TGF-β1 promoter polymorphisms, together with the +25 polymorphism, on the risk of occurrence of AD in a large case-control population of 678 sporadic AD patients and 667 controls. The gene discussed is TGFB1; the disease is Alzheimer disease.